Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
ARID1A mutation + MSI-H
i
Other names:
ARID1A, AT-Rich Interaction Domain 1A, SWI/SNF-Related, Matrix-Associated, Actin-Dependent Regulator Of Chromatin Subfamily F Member 1, AT-Rich Interactive Domain-Containing Protein 1A, AT Rich Interactive Domain 1A (SWI-Like), ARID Domain-Containing Protein 1A, SWI/SNF Complex Protein P270, BRG1-Associated Factor 250a, SWI-Like Protein, Osa Homolog 1, SMARCF1, C1orf4, BAF250, HOSA1, OSA1, AT Rich Interactive Domain 1A (SWI- Like), Chromatin Remodeling Factor P250, BRG1-Associated Factor 250, OS
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
8289
Related biomarkers:
Expression
Mutation
CNA
Others
‹
ARID1A mutation (36)
ARID1A 548fs (2)
ARID1A 756fs (2)
EGFR mutation + TP53 mutation + ARID1A mutation (2)
MSI-H/dMMR + KMT2D mutation (1)
ARID1A K1238fs + FGFR2 R210Q (1)
ARID1A mutation+ KRAS G12C (1)
CXCL13 mutation + ARID1A mutation (1)
TP53 mutation + ARID1A mutation (1)
ARID1A Q2128 (0)
ARID1A mutation (36)
ARID1A 548fs (2)
ARID1A 756fs (2)
EGFR mutation + TP53 mutation + ARID1A mutation (2)
MSI-H/dMMR + KMT2D mutation (1)
ARID1A K1238fs + FGFR2 R210Q (1)
ARID1A mutation+ KRAS G12C (1)
CXCL13 mutation + ARID1A mutation (1)
TP53 mutation + ARID1A mutation (1)
ARID1A Q2128 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
ARID1A mutation + MSI-H
Lung Adenocarcinoma
ARID1A mutation + MSI-H
Lung Adenocarcinoma
cisplatin + pemetrexed
Resistant: C4 – Case Studies
cisplatin + pemetrexed
Resistant
:
C4
cisplatin + pemetrexed
Resistant: C4 – Case Studies
cisplatin + pemetrexed
Resistant
:
C4
ARID1A mutation + MSI-H
Lung Adenocarcinoma
ARID1A mutation + MSI-H
Lung Adenocarcinoma
nivolumab
Resistant: C4 – Case Studies
nivolumab
Resistant
:
C4
nivolumab
Resistant: C4 – Case Studies
nivolumab
Resistant
:
C4
ARID1A mutation + MSI-H
Lung Adenocarcinoma
ARID1A mutation + MSI-H
Lung Adenocarcinoma
Immunotherapy
Resistant: C4 – Case Studies
Immunotherapy
Resistant
:
C4
Immunotherapy
Resistant: C4 – Case Studies
Immunotherapy
Resistant
:
C4
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.